Understanding Reynolds Syndrome: An Overview

Receiving a diagnosis for a rare condition can feel overwhelming. Reynolds syndrome is what doctors call an overlap syndrome, which means it is a unique situation where two distinct autoimmune conditions exist in the same person ^[1][2]. Specifically, it is the combination of Primary Biliary Cholangitis (PBC) and Systemic Sclerosis (SSc), often the limited cutaneous subtype known as CREST syndrome ^[3].

While it might sound daunting to manage two conditions at once, the clinical reality is that patients with Reynolds syndrome often experience a slower liver disease progression compared to those with classical, aggressive PBC ^[4][5].

Understanding the Components

To understand Reynolds syndrome, it helps to look at the two “ingredients” that define it:

1. Primary Biliary Cholangitis (PBC): This is a liver condition where the body’s immune system mistakenly attacks the small bile ducts (tubes that carry bile out of the liver) ^[6]. This can lead to a backup of bile, which can cause inflammation and scarring over time ^[7].
2. Systemic Sclerosis (SSc) / CREST: This is a connective tissue disease that can cause skin thickening and affects blood vessels. In Reynolds syndrome, this is usually the “limited” version, which tends to progress slowly and stays mostly on the hands, face, and feet ^[1].

How Common Is It?

Reynolds syndrome is considered a rare condition. It is found in approximately 2% of people who have systemic sclerosis ^[1]. It is most frequently seen in patients who test positive for anticentromere antibodies (ACA), which are specific markers the immune system produces in certain types of autoimmune disease ^[8].

What to Expect

Doctors refer to the liver component of this overlap as a “favorable phenotype” when compared to isolated PBC ^[4].

• Slower Liver Progression: Compared to people who have PBC alone, those with Reynolds syndrome often have less severe liver damage and a lower risk of developing advanced cirrhosis (severe liver scarring) ^[5][4].
• Vigilant Lung Monitoring: While the skin manifestations are often limited, the risk of developing pulmonary arterial hypertension (PAH) remains a serious concern. This makes regular, proactive screening by your care team absolutely critical ^[5].
• Gradual Systemic Changes: The version of systemic sclerosis involved (CREST/limited) is typically slow-moving, allowing for better long-term management of symptoms like Raynaud’s phenomenon (where fingers turn white or blue in the cold) ^[1].

Moving Forward

While there are no specific “Reynolds-only” international guidelines, doctors treat the syndrome by following the best practices for both PBC and systemic sclerosis ^[9].

Your care will likely involve a team of specialists, including a hepatologist (liver doctor) and a rheumatologist (joint and autoimmune specialist), working together to monitor your health ^[2]. Early recognition and consistent monitoring are the best tools for maintaining a high quality of life.

Learn more about your condition in the following pages: